Malignant neoplasms are one of the most relevant areas of modern medicine. More than 120 thousand people annually. recognized as disabled due to oncological diseases. In the structure of mortality from this class of diseases, about 30% are people of working age [1,5,9].
In the structure of primary disability, malignant neoplasms occupy the 2nd place after diseases of the circulatory system (16-20% of the total number of those who were first recognized as disabled) [1,2,9].
Affected mainly by the population in active working age, up to 90-95% of patients at the initial examination are recognized as invalids of groups I-II [22].
In men, the main disabling disease is lung cancer - 27.8%, in second place - stomach cancer - 11.3%, in third - cancer of the rectum and colon - 11.0%, in fourth - cancer of the larynx - 7.3%. In women, the leading disabling disease is breast cancer - 39.5% and female genital cancer - 26.3%. Cancer of the rectum and colon occupies 9.2% in the structure of primary disability in women [11,12,18].
